These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 23740387)

  • 1. Pro- or anti-inflammatory role of apolipoprotein A-1 in high-density lipoproteins?
    Vuilleumier N; Dayer JM; von Eckardstein A; Roux-Lombard P
    Swiss Med Wkly; 2013; 143():w13781. PubMed ID: 23740387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modification of high density lipoprotein by myeloperoxidase generates a pro-inflammatory particle.
    Undurti A; Huang Y; Lupica JA; Smith JD; DiDonato JA; Hazen SL
    J Biol Chem; 2009 Nov; 284(45):30825-35. PubMed ID: 19726691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formation of dysfunctional high-density lipoprotein by myeloperoxidase.
    Nicholls SJ; Zheng L; Hazen SL
    Trends Cardiovasc Med; 2005 Aug; 15(6):212-9. PubMed ID: 16182131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholesterol-Independent Suppression of Lymphocyte Activation, Autoimmunity, and Glomerulonephritis by Apolipoprotein A-I in Normocholesterolemic Lupus-Prone Mice.
    Black LL; Srivastava R; Schoeb TR; Moore RD; Barnes S; Kabarowski JH
    J Immunol; 2015 Nov; 195(10):4685-98. PubMed ID: 26466956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of high-density lipoprotein in inflammation.
    Navab M; Anantharamaiah GM; Fogelman AM
    Trends Cardiovasc Med; 2005 May; 15(4):158-61. PubMed ID: 16099381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molecular Mechanism and Evaluation Method for Anti-Inflammatory HDL].
    Tanaka N; Ishida T
    Rinsho Byori; 2016 Jan; 64(1):49-56. PubMed ID: 27192797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of anti-chloro
    Lokeshwaran K; Hemadou A; Jayaprakash NS; Prasanna RR; Jacobin-Valat MJ; Dieryck W; Joucla G; Vijayalakshmi MA; Clofent-Sanchez G; Santarelli X; Venkataraman K
    J Immunol Methods; 2019 Nov; 474():112637. PubMed ID: 31386835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carboxyl-Terminal Cleavage of Apolipoprotein A-I by Human Mast Cell Chymase Impairs Its Anti-Inflammatory Properties.
    Nguyen SD; Maaninka K; Lappalainen J; Nurmi K; Metso J; Öörni K; Navab M; Fogelman AM; Jauhiainen M; Lee-Rueckert M; Kovanen PT
    Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):274-84. PubMed ID: 26681753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myeloperoxidase Targets Apolipoprotein A-I for Site-Specific Tyrosine Chlorination in Atherosclerotic Lesions and Generates Dysfunctional High-Density Lipoprotein.
    Jin Z; Zhou L; Tian R; Lu N
    Chem Res Toxicol; 2021 Jun; 34(6):1672-1680. PubMed ID: 33861588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human apolipoprotein A-I exerts a prophylactic effect on high-fat diet-induced atherosclerosis via inflammation inhibition in a rabbit model.
    Li J; Wang W; Han L; Feng M; Lu H; Yang L; Hu X; Shi S; Jiang S; Wang Q; Ye L
    Acta Biochim Biophys Sin (Shanghai); 2017 Feb; 49(2):149-158. PubMed ID: 28069582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myeloperoxidase-derived oxidants modify apolipoprotein A-I and generate dysfunctional high-density lipoproteins: comparison of hypothiocyanous acid (HOSCN) with hypochlorous acid (HOCl).
    Hadfield KA; Pattison DI; Brown BE; Hou L; Rye KA; Davies MJ; Hawkins CL
    Biochem J; 2013 Jan; 449(2):531-42. PubMed ID: 23088652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloperoxidase: an inflammatory enzyme for generating dysfunctional high density lipoprotein.
    Shao B; Oda MN; Oram JF; Heinecke JW
    Curr Opin Cardiol; 2006 Jul; 21(4):322-8. PubMed ID: 16755201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-inflammatory effects of apolipoprotein A-I in the rabbit.
    Patel S; Di Bartolo BA; Nakhla S; Heather AK; Mitchell TW; Jessup W; Celermajer DS; Barter PJ; Rye KA
    Atherosclerosis; 2010 Oct; 212(2):392-7. PubMed ID: 20609437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of high-density lipoprotein in the regulation of the immune response: implications for atherosclerosis and autoimmunity.
    Fernandes das Neves M; Batuca JR; Delgado Alves J
    Immunology; 2021 Oct; 164(2):231-241. PubMed ID: 33934336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased atherosclerosis in mice lacking apolipoprotein A-I attributable to both impaired reverse cholesterol transport and increased inflammation.
    Moore RE; Navab M; Millar JS; Zimetti F; Hama S; Rothblat GH; Rader DJ
    Circ Res; 2005 Oct; 97(8):763-71. PubMed ID: 16151025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloperoxidase targets apolipoprotein A-I, the major high density lipoprotein protein, for site-specific oxidation in human atherosclerotic lesions.
    Shao B; Pennathur S; Heinecke JW
    J Biol Chem; 2012 Feb; 287(9):6375-86. PubMed ID: 22219194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-density lipoprotein and apolipoprotein A-I inhibit palmitate-induced translocation of toll-like receptor 4 into lipid rafts and inflammatory cytokines in 3T3-L1 adipocytes.
    Yamada H; Umemoto T; Kawano M; Kawakami M; Kakei M; Momomura SI; Ishikawa SE; Hara K
    Biochem Biophys Res Commun; 2017 Mar; 484(2):403-408. PubMed ID: 28137586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloperoxidase-mediated oxidation targets serum apolipoprotein A-I in diabetic patients and represents a potential mechanism leading to impaired anti-apoptotic activity of high density lipoprotein.
    Lu N; Xie S; Li J; Tian R; Peng YY
    Clin Chim Acta; 2015 Feb; 441():163-70. PubMed ID: 25528002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The endothelium: an interface between autoimmunity and atherosclerosis in systemic lupus erythematosus?
    Narshi CB; Giles IP; Rahman A
    Lupus; 2011 Jan; 20(1):5-13. PubMed ID: 21138982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysine glycation of apolipoprotein A-I impairs its anti-inflammatory function in type 2 diabetes mellitus.
    Liu D; Ji L; Zhao M; Wang Y; Guo Y; Li L; Zhang D; Xu L; Pan B; Su J; Xiang S; Pennathur S; Li J; Gao J; Liu P; Willard B; Zheng L
    J Mol Cell Cardiol; 2018 Sep; 122():47-57. PubMed ID: 30092227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.